首页> 外国专利> Sell surface tropomyosin as a target of angiogenesis inhibition.

Sell surface tropomyosin as a target of angiogenesis inhibition.

机译:出售表面原肌球蛋白作为抑制血管生成的靶标。

摘要

The present invention is directed to novel methods for inhibiting angiogenesis and treating tumors and cancer by targeting tropomyosin (Tpm) expressed on the surface of endothelial cells and/or tumor cells, to Tpm polypeptides and peptides, as well as variants and derivatives thereof that bind inhibitors of angiogenesis, and to anti-Tpm antibodies that block or stimulate angiogenesis. Cyclic peptides that bind to the D5 subunit of HKSUBa /SUBand inhibit angiogenesis are also included. Method for screening test compounds as candidate antiangiogenic molecule that binds to Tpm are disclosed, as are affinity ligands comprising the proteins, peptides, variants and derivatives of the invention.
机译:本发明涉及通过靶向在内皮细胞和/或肿瘤细胞表面上表达的原肌球蛋白(Tpm),靶向于Tpm多肽和肽及其结合的变体和衍生物,来抑制血管生成和治疗肿瘤和癌症的新方法。血管生成抑制剂和抗Tpm抗体,这些抗体可阻止或刺激血管生成。还包括与HK a 的D5亚基结合并抑制血管生成的环肽。公开了筛选作为与TPM结合的候选抗血管生成分子的测试化合物的方法,以及包含本发明的蛋白质,肽,变体和衍生物的亲和配体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号